- St. Jude Medical,
- Terumo Corp.
- Vasorum Ltd.
- Cardinal Health
- Rex Medical
- Medtronic Essential Medical
- Vivasure
(Note: The list of the major players will be updated with the latest market scenario and trends)
Recent developments by key players in Vascular Sealing Systems Market:
Terumo
Terumo continues to enhance its AngioSeal™ line, which was used in over 2 million procedures in 2023, with success rates exceeding 97%. The company has also received CE certifications for its Angio-Seal VIP and Femoseal devices.
Cardinal Health
In July 2024, Cordis, a subsidiary of Cardinal Health, received FDA premarket approval for the MYNX CONTROL™ VENOUS closure device. This device utilizes an extravascular biodegradable sealant that expands upon contact with blood, ensuring secure closure without leaving any intravascular remnants.